Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Norwegian Pharmacy Association | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
"Medisinstart" is a new service developed for use in Norwegian pharmacies. It is intended for patients that are about to start a new medicine for a chronic or long-term condition. It is based on research showing that problems with newly prescribed medicines appear rapidly and that a significant portion of patients quickly becomes non-adherent. The service consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine.
The main purpose of this study is to investigate whether "Medisinstart" increases patients' adherence to the prescribed medication. Patients' beliefs about their medicines and their motivation for adherence will also be examined. The study also aims at revealing if "Medisinstart" has additional benefits for the patient, the society and the pharmacies.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Medisinstart | Experimental | Patients in this arm will receive the service; Medisinstart |
|
| Current Practice | No Intervention | Patients in this arm will receive the current pharmacy practice of advice and guidance with their new medicine. This involves dispensing the medicine and briefly providing information regarding its use and potential side-effects. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Medisinstart | Other | "Medisinstart" is a newly developed pharmacy service for patients about to start a new medicine for a chronic or long-term condition. It consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine. |
| Measure | Description | Time Frame |
|---|---|---|
| Adherence by Morisky 8-item Medication Adherence Scale (MMAS-8) at 7 weeks | Adherence will be measured by a validated Norwegian translation of the MMAS-8 | 7 weeks after dispensing the new medicine |
| Adherence by Morisky 8-item Medication Adherence Scale (MMAS-8) at 18 weeks | Adherence will be measured by a validated Norwegian translation of the MMAS-8 | 18 weeks after dispensing the new medicine |
| Measure | Description | Time Frame |
|---|---|---|
| Self reported adherence at 7 weeks | Adherence will be measured by a Norwegian translation of the question: "People often miss taking doses of their medicines, for a wide range of reasons. Have you missed any doses of your new medicine the last week?" | 7 weeks after dispensing the new medicine |
| Adherence by Medication Possession Ratio (MPR) at 18 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of reported Medication-Related Problems in the intervention arm | The pharmacist carrying out the intervention will report all discovered Medication-Related Problems | During the intervention |
| Patients' evaluation of "Medisinstart" |
Inclusion Criteria:
First time prescription for a drug belonging to one of the following groups (ATC-code):
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Karine W Ruud, PhD | Apokus AS | Study Director |
| Sara Bremer, PhD | Apokus AS | Study Director |
| Ragnar Hovland, PhD | Photocure ASA (current affiliation), Apokus AS (until Dec. 2016) | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Apotek 1 Alta | Alta | Norway | ||||
| Apotek 1 Andselv |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 15175485 | Background | Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004 Jun;13(3):172-5. doi: 10.1136/qhc.13.3.172. | |
| 24289059 | Background | Boyd M, Waring J, Barber N, Mehta R, Chuter A, Avery AJ, Salema NE, Davies J, Latif A, Tanajewski L, Elliott RA. Protocol for the New Medicine Service Study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in England. Trials. 2013 Dec 1;14:411. doi: 10.1186/1745-6215-14-411. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Adherence by MPR will be calculated from data collected from the Norwegian Prescription Database |
| 18 weeks after dispensing the new medicine |
| Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at inclusion | Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ | At inclusion |
| Self reported adherence at 18 weeks | Adherence will be measured by a Norwegian translation of the question: "People often miss taking doses of their medicines, for a wide range of reasons. Have you missed any doses of your new medicine the last week?" | 18 weeks after dispensing the new medicine |
| Adherence by Medication Possession Ratio (MPR) at 1 year | Adherence by MPR will be calculated from data collected from the Norwegian Prescription Database | 1 year after dispensing the new medicine |
| Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at 7 weeks | Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ | 7 weeks after dispensing the new medicine |
| Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at 18 weeks | Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ | 18 weeks after dispensing the new medicine |
Patients' in the intervention arm will evaluate the service by answering a questionnaire
| 7 weeks after dispensing the new medicine |
| Pharmacists' evaluation of patient benefit | Pharmacists performing the service will answer the following question (translated from Norwegian): "You have currently performed "Medisinstart" with at least 5 patients. Do you regard it to be beneficial for the patients?" | 7 months after start of the study |
| Pharmacy costs by performing the service | Pharmacies will report the COSTs for carrying out the service | 1 year after study start |
| Andselv |
| Norway |
| Boots apotek Harebakken | Arendal | Norway |
| Sykehusapoteket Arendal | Arendal | Norway |
| Boots apotek Moa | Ålesund | Norway |
| Vitusapotek Raumnes | Årnes | Norway |
| Vitusapotek Årnes | Årnes | Norway |
| Apotek 1 Horisont | Bergen | Norway |
| Boots apotek Bryggen | Bergen | Norway |
| Sjukehusapoteket i Bergen | Bergen | Norway |
| Sykehusapoteket i Bodø | Bodø | Norway |
| Apotek 1 Brandbu | Brandbu | Norway |
| Apotek 1 Bømlo | Bremnes | Norway |
| Apotek 1 Åssiden | Drammen | Norway |
| Sykehusapoteket Drammen | Drammen | Norway |
| Boots apotek Elverum | Elverum | Norway |
| Sykehusapoteket Elverum | Elverum | Norway |
| Boots apotek Flisa | Flisa | Norway |
| Apotek 1 Helsehuset Fredrikstad | Fredrikstad | Norway |
| Sjukehusapoteket i Førde | Førde | Norway |
| Boots apotek Hamar | Hamar | Norway |
| Sjukehusapoteket i Haugesund | Haugesund | Norway |
| Apotek 1 Lerka | Kleppe | Norway |
| Apotek 1 Kopervik | Kopervik | Norway |
| Vitusapotek Sørlandssenteret | Kristiansand | Norway |
| Boots apotek Larvik | Larvik | Norway |
| Apotek 1 Lofotsenteret | Leknes | Norway |
| Apotek 1 Malvik | Malvik | Norway |
| Apotek 1 Mandal | Mandal | Norway |
| Ditt apotek Maura | Maura | Norway |
| Ditt apotek Meyer | Mo i Rana | Norway |
| Ditt apotek Ytteren | Mo i Rana | Norway |
| Apotek 1 Sjøsiden | Mosjøen | Norway |
| Vitusapotek Varnaveien Moss | Moss | Norway |
| Apotek 1 Morenen | Mysen | Norway |
| Vitusapotek Nesbru | Nesbru | Norway |
| Apotek 1 St. Hanshaugen senter | Oslo | Norway |
| Boots apotek Bogstadveien | Oslo | Norway |
| Boots apotek Skøyen | Oslo | Norway |
| Boots apotek Solli | Oslo | Norway |
| Diakonhjemmets sykehusapotek | Oslo | Norway |
| Lovisenberg sykehusapotek | Oslo | Norway |
| Sykehusapoteket Oslo, Ullevål | Oslo | Norway |
| Vitusapotek Storo | Oslo | Norway |
| Vitusapotek Raufoss | Raufoss | Norway |
| Apotek 1 Kvadrat | Sandnes | Norway |
| Vitusapotek Ganddal | Sandnes | Norway |
| Vitusapotek Syv Søstre | Sandnessjøen | Norway |
| Apotek 1 Sandvika Storsenter | Sandvika | Norway |
| Sykehusapoteket Bærum | Sandvika | Norway |
| Boots apotek Lande | Sarpsborg | Norway |
| Boots apotek Saupstad | Saupstad | Norway |
| Vitusapotek Selbak | Sellebakk | Norway |
| Apotek 1 Ski Amfi | Ski | Norway |
| Sykehusapoteket Skien | Skien | Norway |
| Apotek 1 Hjorten Stavanger | Stavanger | Norway |
| Sjukehusapoteket i Stavanger | Stavanger | Norway |
| Vitusapotek Løven Stavanger | Stavanger | Norway |
| Vitusapotek Medisinsk senter - Steinkjer | Steinkjer | Norway |
| Sykehusapoteket Lørenskog | Strømmen | Norway |
| Vitusapotek Strømmen storsenter | Strømmen | Norway |
| Vitusapotek K1 Tromsø | Tromsø | Norway |
| Boots apotek Nordre | Trondheim | Norway |
| Vitusapotek Solsiden | Trondheim | Norway |
| Sykehusapoteket Tønsberg | Tønsberg | Norway |
| Vitusapotek Innherred | Verdal | Norway |
| Gausdal apotek | Østre Gausdal | Norway |
| 17004019 | Background | Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006 Jun;28(3):165-70. doi: 10.1007/s11096-006-9026-6. Epub 2006 Sep 27. |
| 17557211 | Background | Elliott RA, Barber N, Clifford S, Horne R, Hartley E. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm World Sci. 2008 Jan;30(1):17-23. doi: 10.1007/s11096-007-9134-y. Epub 2007 Jun 8. |
| 12076376 | Background | Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011. doi: 10.1002/14651858.CD000011. |
| 10661603 | Background | Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999 Dec;47(6):555-67. doi: 10.1016/s0022-3999(99)00057-4. |
| 22353834 | Background | Hov I, Bjartnes M, Slordal L, Spigset O. [Are drugs taken as prescribed?]. Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):418-22. doi: 10.4045/tidsskr.11.0225. Norwegian. |
| 18453793 | Background | Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x. |
| 18049498 | Background | Ruths S, Viktil KK, Blix HS. [Classification of drug-related problems]. Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3073-6. Norwegian. |
| Background | Sabate E. (Ed.) (2003), Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D006973 | Hypertension |
| D050171 | Dyslipidemias |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided